{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:55:42Z","timestamp":1773150942268,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["22K12887"],"award-info":[{"award-number":["22K12887"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00277-023-05243-0","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T04:01:32Z","timestamp":1682913692000},"page":"1549-1559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-7906","authenticated-orcid":false,"given":"Satoshi","family":"Yamasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyakoshi","family":"Shigesaburo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Nawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onizuka","family":"Makoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamitsu","family":"Yanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"5243_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41409-021-01247-4","volume":"56","author":"M Yanada","year":"2021","unstructured":"Yanada M (2021) The evolving concept of indications for allogeneic hematopoietic cell transplantation during first complete remission of acute myeloid leukemia. Bone Marrow Transplant 56:1257\u20131265. https:\/\/doi.org\/10.1038\/s41409-021-01247-4","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR2","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","volume":"29","author":"RB Walter","year":"2011","unstructured":"Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, Appelbaum FR, Kantarjian HA, Estey EH (2011) Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol 29:4417\u20134423. https:\/\/doi.org\/10.1200\/JCO.2011.35.7525","journal-title":"J Clin Oncol"},{"key":"5243_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3324\/haematol.2015.141119","volume":"101","author":"JM Tiercy","year":"2016","unstructured":"Tiercy JM (2016) How to select the best available related or unrelated donor of hematopoietic stem cells? Haematologica 101:680\u2013687. https:\/\/doi.org\/10.3324\/haematol.2015.141119","journal-title":"Haematologica"},{"key":"5243_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/bmt.2012.159","volume":"48","author":"M Yanada","year":"2013","unstructured":"Yanada M, Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Kanamori H, Usuki K, Kobayashi T, Watanabe M, Nagafuji K, Yano S, Nawa Y, Tomiyama J, Tashiro H, Nakamura Y, Fujisawa S, Kimura F, Emi N, Miura I, Fukuda T (2013) Effect of related donor availability on outcome of AML in the context of related and unrelated hematopoietic cell transplantation. Bone Marrow Transplant 48:390\u2013395. https:\/\/doi.org\/10.1038\/bmt.2012.159","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00277-020-04051-0","volume":"99","author":"M Yanada","year":"2020","unstructured":"Yanada M, Takami A, Yamasaki S, Arai Y, Konuma T, Uchida N, Najima Y, Fukuda T, Tanaka M, Ozawa Y, Ikegame K, Takanashi M, Ichinohe T, Okamoto S, Atsuta Y, Yano S (2020) Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century. Ann Hematol 99:1351\u20131360. https:\/\/doi.org\/10.1007\/s00277-020-04051-0","journal-title":"Ann Hematol"},{"key":"5243_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1532\/IJH97.06239","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, Kato K, Tabuchi K, Tsuchida M, Morishima Y, Mitamura M, Kawa K, Kato S, Nagamura T, Takanashi M, Kodera Y (2007) Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 86:269\u2013274. https:\/\/doi.org\/10.1532\/IJH97.06239","journal-title":"Int J Hematol"},{"key":"5243_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","volume":"103","author":"Y Atsuta","year":"2016","unstructured":"Atsuta Y (2016) Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol 103:3\u201310. https:\/\/doi.org\/10.1007\/s12185-015-1894-x","journal-title":"Int J Hematol"},{"key":"5243_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"5243_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2017.1357173","volume":"28","author":"M Yanada","year":"2017","unstructured":"Yanada M, Mori J, Aoki J, Harada K, Mizuno S, Uchida N, Kurosawa S, Toya T, Kanamori H, Ozawa Y, Ogawa H, Henzan H, Iwato K, Sakura T, Ota S, Fukuda T, Ichinohe T, Atsuta Y, Yano S (2017) Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients. Leuk Lymphoma 28:1\u20139. https:\/\/doi.org\/10.1080\/10428194.2017.1357173","journal-title":"Leuk Lymphoma"},{"key":"5243_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reducedintensity conditioning regimen workshop: Defining the dose spectrum\u2014report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 15:367\u2013369. https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.497","journal-title":"Biol Blood Marrow Transplant"},{"key":"5243_CR11","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825\u2013828","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11:945\u2013956. https:\/\/doi.org\/10.1016\/j.bbmt.2005.09.004","journal-title":"Biol Blood Marrow Transplant"},{"key":"5243_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","volume":"125","author":"SG Holtan","year":"2015","unstructured":"Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, Blazar BR, MacMillan ML, Weisdorf DJ (2015) Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 125:1333\u20131338. https:\/\/doi.org\/10.1182\/blood-2014-10-609032","journal-title":"Blood"},{"key":"5243_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/bmt.2015.305","volume":"51","author":"A Ruggeri","year":"2016","unstructured":"Ruggeri A, Labopin M, Ciceri F, Mohty M, Nagler A (2016) Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transplant 51:610\u2013611. https:\/\/doi.org\/10.1038\/bmt.2015.305","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","volume":"16","author":"RJ Gray","year":"1988","unstructured":"Gray RJ (1988) A class of KK-sample tests for comparing the cumulative incidence of a competing risk. Ann Statist 16:1141\u20131154","journal-title":"Ann Statist"},{"key":"5243_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"J Fine","year":"1999","unstructured":"Fine J, Gray R (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"key":"5243_CR17","volume-title":"Evaluation of Chemotherapeutic Agents","author":"DA Karnofsky","year":"1949","unstructured":"Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of Chemotherapeutic Agents. Columbia University Press:191\u2013205, New York"},{"key":"5243_CR18","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912\u20132919. https:\/\/doi.org\/10.1182\/blood-2005-05-2004","journal-title":"Blood"},{"key":"5243_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR20","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P et al (2012) Confer DL; Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 367:1487\u20131496. https:\/\/doi.org\/10.1056\/NEJMoa1203517","journal-title":"N Engl J Med"},{"key":"5243_CR21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12185-010-0581-1","volume":"91","author":"K Nagafuji","year":"2010","unstructured":"Nagafuji K, Matsuo K, Teshima T, Mori S, Sakamaki H, Hidaka M, Ogawa H, Kodera Y, Kanda Y, Maruta A, Mori T, Yoshiba F, Ichinohe T, Kasai M, Takatsuka Y, Kubo K, Sao H, Atsuta Y, Suzuki R et al (2010) Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry. Int J Hematol 91:855\u2013864. https:\/\/doi.org\/10.1007\/s12185-010-0581-1","journal-title":"Int J Hematol"},{"key":"5243_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.bbmt.2012.09.017","volume":"19","author":"J Kanda","year":"2013","unstructured":"Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Aotsuka N, Onishi Y, Kato K, Nagamura-Inoue T, Kanda Y, HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation (2013) Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation. Biol Blood Marrow Transplant 19:247\u2013254. https:\/\/doi.org\/10.1016\/j.bbmt.2012.09.017","journal-title":"Biol Blood Marrow Transplant"},{"key":"5243_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bbmt.2015.10.006","volume":"22","author":"S Terakura","year":"2016","unstructured":"Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K, Japan Society for Hematopoietic Cell Transplantation (2016) Comparison of outcomes of 8\/8 and 7\/8 allele-matched unrelated bone marrow transplantation and single-unit cord blood transplantation in adults with acute leukemia. Biol Blood Marrow Transplant 22:330\u2013338. https:\/\/doi.org\/10.1016\/j.bbmt.2015.10.006","journal-title":"Biol Blood Marrow Transplant"},{"key":"5243_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/ejh.12723","volume":"97","author":"M Yanada","year":"2016","unstructured":"Yanada M, Kanda J, Ohtake S, Fukuda T, Sakamaki H, Miyamura K, Miyawaki S, Uchida N, Maeda T, Nagamura-Inoue T, Asou N, Morishima Y, Atsuta Y, Miyazaki Y, Kimura F, Kobayashi Y, Takami A, Naoe T, Kanda Y (2016) Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. Eur J Haematol 97:278\u2013287. https:\/\/doi.org\/10.1111\/ejh.12723","journal-title":"Eur J Haematol"},{"key":"5243_CR25","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1007\/s00277-020-04261-6","volume":"99","author":"S Yamasaki","year":"2020","unstructured":"Yamasaki S, Mori J, Kanda J, Imahashi N, Uchida N, Doki N, Tanaka M, Katayama Y, Eto T, Ozawa Y, Takada S, Onizuka M, Hino M, Kanda Y, Fukuda T, Atsuta Y, Yanada M (2020) Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT. Ann Hematol 99:2927\u20132937. https:\/\/doi.org\/10.1007\/s00277-020-04261-6","journal-title":"Ann Hematol"},{"key":"5243_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00006454-200203000-00013","volume":"21","author":"DK Benjamin Jr","year":"2002","unstructured":"Benjamin DK Jr, Miller WC, Bayliff S, Martel L, Alexander KA (2002) Martin PL (2002) Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J. 21:227\u2013234. https:\/\/doi.org\/10.1097\/00006454-200203000-00013","journal-title":"Pediatr Infect Dis J."},{"key":"5243_CR27","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1056\/NEJMoa041276","volume":"351","author":"MJ Laughlin","year":"2004","unstructured":"Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265\u20132275. https:\/\/doi.org\/10.1056\/NEJMoa041276","journal-title":"N Engl J Med"},{"key":"5243_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ajh.25705","volume":"95","author":"T Konuma","year":"2020","unstructured":"Konuma T, Kanda J, Inamoto Y, Hayashi H, Kobayashi S, Uchida N, Sugio Y, Tanaka M, Kobayashi H, Kouzai Y, Takahashi S, Eto T, Mukae J, Matsuhashi Y, Fukuda T, Takanashi M, Kanda Y, Atsuta Y, Kimura F (2020) Improvement of early mortality in single-unit cord blood transplantation for Japanese adults from 1998 to 2017. Am J Hematol 95:343\u2013353. https:\/\/doi.org\/10.1002\/ajh.25705","journal-title":"Am J Hematol"},{"key":"5243_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bbmt.2018.02.008","volume":"24","author":"M Ogata","year":"2018","unstructured":"Ogata M, Takano K, Moriuchi Y, Kondo T, Ueki T, Nakano N, Mori T, Uoshima N, Nagafuji K, Yamasaki S, Shibasaki Y, Sakai R, Kato K, Choi I, Jo Y, Eto T, Kako S, Oshima K (2018) Fukuda T (2018) Effects of prophylactic Foscarnet on human herpesvirus-6 reactivation and encephalitis in cord blood transplant recipients: a prospective multicenter trial with an historical control group. Biol Blood Marrow Transplant. 24:1264\u20131273. https:\/\/doi.org\/10.1016\/j.bbmt.2018.02.008","journal-title":"Biol Blood Marrow Transplant."},{"key":"5243_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41409-019-0499-z","volume":"55","author":"SO Ciurea","year":"2020","unstructured":"Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ, Ciceri F, Locatelli F, Aversa F, Castagna L, Bacigalupo A, Martelli M, Blaise D, Ben Soussan P, Arnault Y, Handgretinger R, Roy DC, O\u2019Donnell PV, Bashey A et al (2020) The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant 55:12\u201324. https:\/\/doi.org\/10.1038\/s41409-019-0499-z","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41409-018-0279-1","volume":"54","author":"J Sugita","year":"2019","unstructured":"Sugita J, Kagaya Y, Miyamoto T, Shibasaki Y, Nagafuji K, Ota S, Furukawa T, Nara M, Akashi K, Taniguchi S, Harada M, Matsuo K, Teshima T, Japan Study Group for Cell Therapy and Transplantation (JSCT) (2019) Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide. Bone Marrow Transplant 54:432\u2013441. https:\/\/doi.org\/10.1038\/s41409-018-0279-1","journal-title":"Bone Marrow Transplant"},{"key":"5243_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00277-016-2872-y","volume":"96","author":"S Yamasaki","year":"2017","unstructured":"Yamasaki S, Hirakawa A, Aoki J, Uchida N, Fukuda T, Ogawa H, Ohashi K, Kondo T, Eto T, Kanamori H, Okumura H, Iwato K, Ichinohe T, Kanda J, Onizuka M, Kuwatsuka Y, Yanada M, Atsuta Y, Takami A, Yano S (2017) Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia. Ann Hematol 96:289\u2013297. https:\/\/doi.org\/10.1007\/s00277-016-2872-y","journal-title":"Ann Hematol"},{"key":"5243_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K et al (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481:506\u2013510. https:\/\/doi.org\/10.1038\/nature10738","journal-title":"Nature"},{"key":"5243_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1182\/blood-2012-04-427039","volume":"121","author":"B Parkin","year":"2013","unstructured":"Parkin B, Ouillette P, Li Y, Keller J, Lam C, Roulston D, Li C, Shedden K, Malek SN (2013) Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia. Blood 121:369\u2013377. https:\/\/doi.org\/10.1182\/blood-2012-04-427039","journal-title":"Blood"},{"key":"5243_CR35","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bjh.13873","volume":"172","author":"GJ Dickson","year":"2016","unstructured":"Dickson GJ, Bustraan S, Hills RK, Ali A, Goldstone AH, Burnett AK, Linch DC, Gale RE (2016) The value of molecular stratification for CEBPA(DM) and NPM1(MUT) FLT3(WT) genotypes in older patients with acute myeloid leukaemia. Br J Haematol 172:573\u2013580. https:\/\/doi.org\/10.1111\/bjh.13873","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05243-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05243-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:19:46Z","timestamp":1683886786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05243-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5243"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05243-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"13 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Data Management Committee of the Japanese Society for Hematopoietic Cell Transplantation and the Institutional Review Board of Kyushu University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The Transplant Registry Unified Management Program database contains physician-reviewed data. Observational studies based on the Transplant Registry Unified Management Program database are performed with informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}